XML 121 R36.htm IDEA: XBRL DOCUMENT v3.25.3
Common Stock (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 14, 2025
Aug. 04, 2025
Jul. 07, 2025
May 01, 2025
Feb. 11, 2025
Dec. 05, 2024
Aug. 08, 2024
Mar. 12, 2024
Sep. 23, 2025
Sep. 18, 2025
Jul. 23, 2025
Jun. 15, 2025
May 28, 2025
Mar. 24, 2025
Mar. 20, 2025
May 20, 2022
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Dec. 31, 2024
Common stock, shares authorized                                 325,000,000         325,000,000 325,000,000
Common stock shares issued during period, shares     991,000 1,958,273         608,000 483,870                          
Common stock shares issued during period, value     $ 991 $ 1,958         $ 608               $ 2,005,818 $ 60,604 $ 2,384,654 $ 589,488 $ 15,734    
Exercise price per share     $ 0.001 $ 0.001         $ 0.001 $ 0.682                          
Proceed from issuance and sale of shares and warrants   $ 1,210,000       $ 1,900,000       $ 300,000                          
Offering expenses   $ 100,000       $ 100,000       $ 20,000.00                          
Combined offering price                   $ 0.62                          
Common stock, shares par value                                 $ 0.001         $ 0.001 $ 0.001
Common stock, shares issued                                 109,620,405         109,620,405 96,097,485
Common stock, shares outstanding                                 109,620,405         109,620,405 96,097,485
Number of warrants issued                   483,870                          
Issued shares of restricted common stock                                           1,428,500  
Stock Options [Member]                                              
Options, cancelled in period         40,000           292,000 51,722 171,291   26,200                
Securities Purchase Agreement [Member]                                              
Agreement of several purchases offering, Description   (i) 156,250 shares of the Company’s common stock to certain of its directors and executive officers (collectively, the “Insider Purchasers”) at an offering price of $0.64 per share (the “August 2025 Insider Shares”), and (ii) 1,734,375 shares of common stock (the “August 2025 Warrant Investor Shares” and, together with the August 2025 Insider Shares, the “August 2025 Shares”), together with common stock purchase warrants to purchase up to 1,734,735 shares of common stock (the “August 2025 Warrants”), at a combined offering price of $0.64 per August 2025 Warrant Investor Share and accompanying August 2025 Warrant, to certain other existing stockholders of the Company. Each August 2025 Warrant has an exercise price per share of $0.768, and is exercisable on or after August 4, 2025 through and until August 4, 2030. The Insider Purchasers did not receive any August 2025 Warrants in the offering       (i) 445,648 shares to the Insider Investors at an offering price of $0.5722 per share and (ii) a further 2,857,389 shares of our common stock (the “December 2024 Warrant Investor Shares” and, together with the Insider Shares, the “December 2024 Shares”), together with 2,857,389 common stock purchase warrants to purchase up to 2,857,389 shares of our common stock (the “Form A Warrants”) and 2,857,389 common stock purchase warrants to purchase up to 1,428,693 shares of our common stock (the “Form B Warrants” and, together with the Form A Warrants, the “December 2024 Warrants”), at a combined offering price of $0.5722 per December 2024 Warrant Investor Share and accompanying December 2024 Warrants, to certain existing stockholders of the Company and new investors. The December 2024 Shares, Form A Warrants, and Form B Warrants were separately issued. Each Form A Warrant has an exercise price per share of $0.5722 and each Form B Warrant has an exercise price per share of $0.71525. Each December 2024 Warrant is exercisable on or after December 9, 2024 through and until December 9, 2029               (i) 2,363,636 shares of the Company’s common stock to certain of its directors and executive officers, and certain of its existing stockholders (collectively, the “Insiders”) at an offering price of $0.55 per share (the “Insider Shares”), and (ii) 1,739,087 shares of common stock (the “March 2025 Warrant Investor Shares” and, together with the Insider Shares, the “March 2025 Shares”), together with common stock purchase warrants to purchase up to 1,739,087 shares of common stock (the “March 2025 Warrants”), at a combined offering price of $0.55 per March 2025 Warrant Investor Share and accompanying March 2025 Warrant, to certain other existing stockholders of the Company and new investors. Each March 2025 Warrant has an exercise price per share of $0.66, and is exercisable on or after March 26, 2025 through and until March 26, 2030. The Insiders did not receive any March 2025 Warrants in the offering. The net proceeds received by the Company for the issuance and sale of the March 2025 Shares and the March 2025 Warrants were $2.3 million, before deducting offering expenses of $0.1 million paid by the Company                  
Common stock shares sold             9,170,000                                
Pre-funded warrants             3,557,273                                
Exercise price             $ 0.001                                
Offering price             $ 0.55                                
Offering expenses             $ 100,000                                
Issuance and sale of the Securities             $ 6,400,000                                
Warrants issued to purchase common shares             381,818                                
Securities Purchase Agreement [Member] | Series B Warrants [Member]                                              
Pre-funded warrants             12,727,273                                
Exercise price             $ 0.57                                
Securities Purchase Agreement [Member] | Series A Warrants [Member]                                              
Pre-funded warrants             12,727,273                                
Exercise price             $ 0.57                                
Offering price             $ 0.549                                
License Agreement                                              
Issued shares of restricted common stock               129,132                              
Price per share               $ 0.97                              
2022 EDA [Member]                                              
Common stock shares sold                                           1,945,838  
Commissions and fee                                           $ 2,400,000  
Equity Distribution Agreement [Member]                                              
Common stock shares sold                                           448,706  
Offering price                               $ 25.0              
Commissions and fee                                           $ 262,484  
2025 ATM Sales Agreement [Member]                                              
Amendment description the Company entered into Amendment No. 1 to the 2025 ATM Sales Agreement to increase the maximum aggregate offering price of shares of common stock that may be offered, issued, and sold under the 2025 ATM Sales Agreement from $7.5 million to $30.0 million                                            
Description of sales agreement                                           the Company entered into a Capital On DemandTM Sales Agreement (the “2025 ATM Sales Agreement”) with JonesTrading Institutional Services, LLC (“JonesTrading”) to sell shares of the Company's common stock, with an aggregate offering price of up to $7.5 million, from time to time through an “at the market” offering pursuant to the Company's Registration Statement on Form S-3 filed November 8, 2024  
Common stock shares sold                                           1,386,223  
Commissions and fee                                           $ 880,862